Loading
Latest filing published 29 Jun 2023 for Aldeyra Therapeutics, Inc., €4,838. Read the official filing
No signal scores available.
Our data holds just one disclosure by Ben Bronstein, dated 29 June 2023, reporting an option exercise worth €4,838 in Aldeyra Therapeutics, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration